Literature DB >> 22065226

Fluorescence-based proteasome activity profiling.

Annemieke de Jong1, Karianne G Schuurman, Boris Rodenko, Huib Ovaa, Celia R Berkers.   

Abstract

With the proteasome emerging as a therapeutic target for cancer treatment, accurate tools for monitoring proteasome (inhibitor) activity are in demand. In this chapter, we describe the synthesis and use of a fluorescent proteasome activity probe that allows for accurate profiling of proteasomal activity in cell lysates, intact cells, and murine and human patient-derived material, with high sensitivity using SDS-PAGE. The probe allows for direct scanning of the gel for fluorescent emission of the distinct proteasomal subunits and circumvents the use of Western blot analysis. Due to its suitable biochemical and biophysical properties, the fluorescent probe can also be used for confocal laser scanning microscopy and flow cytometry-based experiments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22065226     DOI: 10.1007/978-1-61779-364-6_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules.

Authors:  Celia R Berkers; Annemieke de Jong; Karianne G Schuurman; Carsten Linnemann; Hugo D Meiring; Lennert Janssen; Jacques J Neefjes; Ton N M Schumacher; Boris Rodenko; Huib Ovaa
Journal:  J Immunol       Date:  2015-09-23       Impact factor: 5.422

2.  Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage.

Authors:  Celia R Berkers; Annemieke de Jong; Karianne G Schuurman; Carsten Linnemann; Jan A J Geenevasen; Ton N M Schumacher; Boris Rodenko; Huib Ovaa
Journal:  J Immunol       Date:  2015-09-23       Impact factor: 5.422

3.  Cellular senescence and protein degradation: breaking down cancer.

Authors:  Xavier Deschênes-Simard; Frédéric Lessard; Marie-France Gaumont-Leclerc; Nabeel Bardeesy; Gerardo Ferbeyre
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

4.  Androgen receptor polyglutamine expansion drives age-dependent quality control defects and muscle dysfunction.

Authors:  Samir R Nath; Zhigang Yu; Theresa A Gipson; Gregory B Marsh; Eriko Yoshidome; Diane M Robins; Sokol V Todi; David E Housman; Andrew P Lieberman
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

5.  Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways.

Authors:  Juliana Navarro-Yepes; Annadurai Anandhan; Erin Bradley; Iryna Bohovych; Bo Yarabe; Annemieke de Jong; Huib Ovaa; You Zhou; Oleh Khalimonchuk; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Mol Neurobiol       Date:  2015-09-26       Impact factor: 5.590

6.  Calcitonin Gene-Related Peptide Induces HIV-1 Proteasomal Degradation in Mucosal Langerhans Cells.

Authors:  Morgane Bomsel; Yonatan Ganor
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 7.  Activity-based imaging probes of the proteasome.

Authors:  Kimberly Cornish Carmony; Kyung Bo Kim
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

8.  Solid-Phase Synthesis and Application of a Clickable Version of Epoxomicin for Proteasome Activity Analysis.

Authors:  Andres F Salazar-Chaparro; Saayak Halder; Marianne E Maresh; Darci J Trader
Journal:  Chembiochem       Date:  2022-02-21       Impact factor: 3.461

9.  Immunoproteasome Activity and Content Determine Hematopoietic Cell Sensitivity to ONX-0914 and to the Infection of Cells with Lentiviruses.

Authors:  Elmira Vagapova; Alexander Burov; Daria Spasskaya; Timofey Lebedev; Tatiana Astakhova; Pavel Spirin; Vladimir Prassolov; Vadim Karpov; Alexey Morozov
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

10.  TDP-43 proteinopathy occurs independently of autophagic substrate accumulation and underlies nuclear defects in Niemann-Pick C disease.

Authors:  Elaine A Liu; Erika Mori; Fuko Hamasaki; Andrew P Lieberman
Journal:  Neuropathol Appl Neurobiol       Date:  2021-06-15       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.